Home Pharmacognosy LU’s High-Tech Pharmaceutical Institute to be Completed by Next Year | Lucknow News

LU’s High-Tech Pharmaceutical Institute to be Completed by Next Year | Lucknow News

0


Lucknow: Students aspiring to a career in pharmacy will soon have a dedicated government institute in the city to make their dreams come true.
Lucknow University is preparing to open an Institute of Pharmaceutical Sciences (IPS) covering a vast area of ​​8,170 square meters on its second campus in Jankipuram.
The proposal to open the institute under the leadership of the Faculty of Engineering was given the green light at the university’s finance committee meeting and it will now be submitted to the executive committee on June 11 for final approval.
The three-story high-tech building will be equipped with four state-of-the-art laboratories and gradually developed into a dedicated research institute with the establishment of modern laboratories for microbiology, pharmaceutical chemistry, central instrumentation, biotechnology, human anatomy, physiology and pharmacognosy.
Construction work on the institute is expected to be completed by next year, by then pharmacy classes will be held on one floor of LU’s engineering faculty.
Two self-funded courses – license in pharmacy (BPharma) with 100 places and diploma in pharmacy (DPharma) with 60 places – will be offered at the institute for which 33 contractual faculties will be designated.
Application for two courses for the 2020-2021 academic session will be invited shortly once the university receives approval from the Pharmacy Council of India.
IPS will include four departments: pharmacy, pharmaceutical chemistry, pharmacology and pharmacognosy.
The BPharma course will be four years (eight semesters) while D Pharma will be two years (annual model). The M Pharma course can start after two years in accordance with the policy of the Pharmacy Council of India, New Delhi.
“The main objective of the institute is to excel in teaching pharmacy, to engage in cutting-edge research to advance healthcare and drug discovery, which is the need for l ‘Time for the Covid 19 pandemic. Innovative research in pharmaceutical, biomedical and clinical sciences and practices will be targeted, ”said IPS director Professor Naveen Khare.

FacebookTwitterLinkedinE-mail


LEAVE A REPLY

Please enter your comment!
Please enter your name here